Abstract
Sickle cell hemoglobin (HbS) is an example of a genetic variant of human hemoglobin where a point mutation in the β globin gene results in substitution of glutamic acid to valine at sixth position of the β globin chain. Association between tetrameric hemoglobin molecules through noncovalent interactions between side chain residue of βVal6 and hydrophobic grooves formed by βAla70, βPhe85 and βLeu88 amino acid residues of another tetramer followed by the precipitation of the elongated polymer leads to the formation of sickle-shaped RBCs in the deoxygenated state of HbS. There are multiple non-covalent interactions between residues across intra- and inter-strands that stabilize the polymer. The clinical phenotype of sickling of RBCs manifests as sickle cell anemia, which was first documented in the year 1910 in an African patient. Although the molecular reason of the disease has been understood well over the decades of research and several treatment procedures have been explored to date, an effective therapeutic strategy for sickle cell anemia has not been discovered yet. Surprisingly, it has been observed that the oxy form of HbS and glutathionylated form of deoxy HbS inhibits polymerization. In addition to describe the residue level interactions in the HbS polymer that provides its stability, here we explain the mechanism of inhibition in the polymerization of HbS in its oxy state. Additionally, we reported the molecular insights of inhibition in the polymerization for glutathionyl HbS, a posttranslational modification of hemoglobin, even in its deoxy state. In this chapter we briefly consider the available treatment procedures of sickle cell anemia and propose that the elevation of glutathionylation of HbS within RBCs, without inducing oxidative stress, might be an effective therapeutic strategy for sickle cell anemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adachi KAT (1978) Demonstration of a delay time during aggregation of diluted solutions of deoxyhemoglobin S and hemoglobin CHarlem in concentrated phosphate buffer. J Biol Chem 253:6641–6643
Adachi KAT (1979) Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations. J Biol Chem 254:7765–7771
Alvino GM, Collingwood D, Murphy JM et al (2007) Replication in hydroxyurea: it’s a matter of time. Mol Cell Biol 27:6396–6406. https://doi.org/10.1128/mcb.00719-07
Balla J, Jacob HS, Balla G et al (1993) Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci 90:9285–9289. https://doi.org/10.1073/pnas.90.20.9285
Belhassen L (2001) Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 97:1584–1589. https://doi.org/10.1182/blood.V97.6.1584
Birchmeier W, Tuchschmid PE, Winterhalter KH (1973) Comparison of human hemoglobin a carrying glutathione and a mixed disulfide with the naturally occurring human hemoglobin A3. Biochemistry 12:3667–3672. https://doi.org/10.1021/bi00743a015
Branden C, Tooze J (1998) Introduction of protein structure, p 43
Brugnara C (2001) Therapeutic strategies for prevention of sickle cell dehydration. Blood Cells Mol Dis 27:71–80. https://doi.org/10.1006/bcmd.2000.0366
Brugnara C (2018) Sickle cell dehydration: pathophysiology and therapeutic applications. Clin Hemorheol Microcirc 68:187–204. https://doi.org/10.3233/CH-189007
Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762–769. https://doi.org/10.1146/annurev.nutr.23.011702.073027
Cavaliere A, Bufalari AVR (1987) 5-azacytidine carcinogenesis in BALB/c mice. Cancer Lett 37:51–58. https://doi.org/10.1016/0304-3835(87)90145-5
Chan AC (2000) A cocktail approach to antioxidant therapy. Nutrition 16:1098–1100. https://doi.org/10.1016/S0899-9007(00)00445-7
Charache S, Dover G, Smith K et al (1983) Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the γ-δ-β-globin gene complex. Proc Natl Acad Sci USA 80:4842–4846. https://doi.org/10.1073/pnas.80.15.4842
Chou ST, Jackson T, Vege S et al (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. https://doi.org/10.1182/blood-2013-03-490623
Christoph GW, Hofrichter J, Eaton WA (2005) Understanding the shape of sickled red cells. Biophys J 88:1371–1376. https://doi.org/10.1529/biophysj.104.051250
Colombo G, Dalle-Donne I, Giustarini D et al (2010) Cellular redox potential and hemoglobin S-glutathionylation in human and rat erythrocytes: a comparative study. Blood Cells Mol Dis 44:133–139. https://doi.org/10.1016/j.bcmd.2009.11.005
Craescu CT, Poyart C, Schaeffer C et al (1986) Covalent binding of glutathione to hemoglobin. II. functional consequences and structural changes reflected in NMR spectra. J Biol Chem 261:14710–14716
da Fonseca SF, Amorim T, Purificação A et al (2015) Hemoglobin A2 values in sickle cell disease patients quantified by high performance liquid chromatography and the influence of alpha thalassemia. Rev Bras Hematol Hemoter 37:296–301. https://doi.org/10.1016/j.bjhh.2015.05.005
Das R, Mitra G, Mathew B et al (2013) Automated analysis of hemoglobin variants using nanoLC-MS and customized databases. J Proteome Res 12:3215–3222. https://doi.org/10.1021/pr4000625
Das R, Muralidharan M, Mitra G et al (2015) Mass spectrometry based characterization of Hb Beckman variant in a falsely elevated HbA1c sample. Anal Biochem 489:53–58. https://doi.org/10.1016/j.ab.2015.07.010
Das R, Mitra G, Mathew B et al (2016) Mass spectrometry-based diagnosis of hemoglobinopathies: a potential tool for the screening of genetic disorder. Biochem Genet 54:816–825. https://doi.org/10.1007/s10528-016-9758-5
Das R, Mitra A, Bhat V, Mandal AK (2017) Application of isotope exchange based mass spectrometry to understand the mechanism of inhibition of sickle hemoglobin polymerization upon oxygenation. J Struct Biol 199:76–83. https://doi.org/10.1016/j.jsb.2017.04.009
Das R, Mitra A, Mitra G et al (2018) Molecular insights of inhibition in sickle hemoglobin polmerization upon glutathionylation: hydrogen/deuterium exchange mass spectrometry and molecular dynamics simulation-based approach. Biochem J 475:2153–2166. https://doi.org/10.1042/BCJ20180306
Eaton WA, Hofrichter J (1987) Hemoglobin S gelation and sickle cell disease. Blood 70:1245–1266
Edelstein SJ (1981) Molecular topology in crystals and fibers of hemoglobin S. J Mol Biol 150:557–575. https://doi.org/10.1016/0022-2836(81)90381-8
Egini O, Guillaume EJA (2017) Effect of Vitamin C on reactive oxygen species formation in erythrocytes of sickle cell anemia patients. Blood 130:4778
Elford HL (1968) Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 33:129–135. https://doi.org/10.1016/0006-291X(68)90266-0
Embury S et al (1994) Sickle cell disease. Basic principles and clinical practice. Raven Press
Fasanmade AA (1996) Gelation kinetics of dilute hemoglobin from sickle cell anemia patients. Hemoglobin. https://doi.org/10.3109/03630269609005845
Ferrone FA, Hofrichter J, Eaton WA (1985a) Kinetics of sickle hemoglobin polymerization. I. studies using temperature-jump and laser photolysis techniques. J Mol Biol 183:591–610. https://doi.org/10.1016/0022-2836(85)90174-3
Ferrone FA, Hofrichter J, Eaton WA (1985b) Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. J Mol Biol 183:611–631. https://doi.org/10.1016/0022-2836(85)90175-5
Garel MC, Domenget C, Caburi-Martin J et al (1986) Covalent binding of glutathione of hemoglobin. I. inhibition of hemoglobin S polymerization. J Biol Chem 261:14704–14709
Ghatge MS, Ahmed MH, Omar ASM et al (2016) Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation. J Struct Biol 194:446–450. https://doi.org/10.1016/j.jsb.2016.04.003
Ginder GD (2015) Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl Res 165:115–125. https://doi.org/10.1016/j.trsl.2014.05.002
Gizi A, Papassotiriou I, Apostolakou F et al (2011) Assessment of oxidative stress in patients with sickle cell disease: the glutathione system and the oxidant-antioxidant status. Blood Cells Mol Dis 46:220–225. https://doi.org/10.1016/j.bcmd.2011.01.002
Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol
Halsey C, Roberts IAG (2003) The role of hydroxyurea in sickle cell disease. Br J Haematol 120:177–186. https://doi.org/10.1046/j.1365-2141.2003.03849.x
Harrington DJ, Adachi K, Royer WE (1997) The high resolution crystal structure of deoxyhemoglobin S. J Mol Biol 272:398–407. https://doi.org/10.1006/jmbi.1997.1253
HbVar Menu. http://globin.cse.psu.edu/hbvar/menu.html. Accessed 12 Oct 2019
Hebbel R (1994) Sickle cell disease: basic principles and clinical practice
Hinkle LE, Wolf S (1949) Experimental study of life situations, emotions, and the occurrence of acidosis in a juvenile diabetic. Am J Med Sci 5:159–160. https://doi.org/10.1097/00000441-194902000-00002
Hoban MD, Orkin SH, Bauer DE (2016) Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease. Blood 127:839–848. https://doi.org/10.1182/blood-2015-09-618587
Hoffman R, Benz EJ, Silberstein LE et al (2017) Hematology: basic principles and practice
Hofrichter J, Ross PD, Eaton WA (1974) Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natl Acad Sci USA 71:4864–4868. https://doi.org/10.1073/pnas.71.12.4864
Hoofnagle AN, Resing KA, Ahn NG (2003) Protein analysis by hydrogen exchange mass spectrometry. Annu Rev Biophys Biomol Struct 32:1–25. https://doi.org/10.1146/annurev.biophys.32.110601.142417
Ingram VM (1956) A specific chemical difference between the globins of normal human and sickle-cell anæmia hæmoglobin. Nature 178:792–794. https://doi.org/10.1038/178792a0
Jeney V (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood 100:879–887. https://doi.org/10.1182/blood.V100.3.879
Joiner CH (2008) Gardos pathway to sickle cell therapies? Blood
Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747. https://doi.org/10.1373/clinchem.2004.034991
Kassim AA, Sharma D (2017) Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape. Hematol Oncol Stem Cell Ther 10:259–266. https://doi.org/10.1016/j.hemonc.2017.05.008
Kemmer G, Keller S (2010) Nonlinear least-squares data fitting in excel spreadsheets. Nat Protoc 5:267–281. https://doi.org/10.1038/nprot.2009.182
Kim-Shapiro DB, King SB, Shields H et al (1999) The reaction of deoxy-sickle cell hemoglobin with hydroxyurea. Biochim Biophys Acta Gen Subj 1428:381–387. https://doi.org/10.1016/S0304-4165(99)00071-9
Knee KM, Roden CK, Flory MR, Mukerji I (2007) The role of β93 Cys in the inhibition of Hb S fiber formation. Biophys Chem 127:181–193. https://doi.org/10.1016/j.bpc.2007.02.002
Koç A, Wheeler LJ, Mathews CK, Merrill GF (2004) Hydroxyurea Arrests DNA replication by a mechanism that preserves basal dNTP pools. J Biol Chem 279:223–230. https://doi.org/10.1074/jbc.M303952200
Lauer J, Shen C-KJ, Maniatis T (1980) The chromosomal arrangement of human α-like globin genes: sequence homology and α-globin gene deletions. Cell 20:119–130. https://doi.org/10.1016/0092-8674(80)90240-8
Lou MF (2000) Thiol regulation in the lens. J Ocul Pharmacol Ther 16:137–148. https://doi.org/10.1089/jop.2000.16.137
Lou MF (2003) Redox regulation in the lens. Prog Retin Eye Res 22:657–682. https://doi.org/10.1016/S1350-9462(03)00050-8
Mandal AK, Woodi M, Sood V et al (2007) Quantitation and characterization of glutathionyl haemoglobin as an oxidative stress marker in chronic renal failure by mass spectrometry. Clin Biochem. https://doi.org/10.1016/j.clinbiochem.2007.05.006
Mandal AK, Bisht S, Bhat VS et al (2008) Electrospray mass spectrometric characterization of hemoglobin Q (Hb Q-India) and a double mutant hemoglobin S/D in clinical samples. Clin Biochem 41:75–81. https://doi.org/10.1016/j.clinbiochem.2007.09.006
Marouf R (2011) Blood transfusion in sickle cell disease. Hemoglobin. https://doi.org/10.3109/03630269.2011.596984
Mathew B, Bhat V, Mandal AK (2011) Analysis of hemoglobin variants using nondenaturing gel electrophoresis and matrix-assisted laser desorption ionization mass spectrometry. Anal Biochem 416:135–137. https://doi.org/10.1016/j.ab.2011.04.029
Matte A, Mazzi F, Federti E et al (2019) New therapeutic options for the treatment of sickle cell disease. Mediterr J Hematol Infect Dis 11:e2019002. https://doi.org/10.4084/mjhid.2019.002
McCune SL, Reilly MP, Chomo MJ et al (1994) Recombinant human hemoglobins designed for gene therapy of sickle cell disease. Proc Natl Acad Sci USA 91:9852–9856. https://doi.org/10.1073/pnas.91.21.9852
McGoron AJ, Joiner CH, Palascak MB, Claussen WJFR (2000) Dehydration of mature and immature sickle red blood cells during fast oxygenation/deoxygenation cycles: role of KCl cotransport and extracellular calcium. Blood 95:2164–2168
Mitra G, Muralidharan M, Pinto J et al (2011) Structural perturbation of human hemoglobin on glutathionylation probed by hydrogen–deuterium exchange and MALDI mass spectrometry. Bioconjug Chem 22:785–793. https://doi.org/10.1021/bc100602f
Mitra G, Muralidharan M, Narayanan S et al (2012) Glutathionylation induced structural changes in oxy human hemoglobin analyzed by backbone amide hydrogen/deuterium exchange and MALDI-mass spectrometry. Bioconjug Chem 23:2344–2353. https://doi.org/10.1021/bc300291u
Nagel RL (2003) Hemoglobin disorders. Humana Press, New Jersey
Narayanan S, Mitra G, Muralidharan M et al (2015) Protein structure-function correlation in living human red blood cells probed by isotope exchange-based mass spectrometry. Anal Chem 87:11812–11818. https://doi.org/10.1021/acs.analchem.5b03217
Newman SF, Sultana R, Perluigi M et al (2007) An increase in S-glutathionylated proteins in the Alzheimer’s disease inferior parietal lobule, a proteomics approach. J Neurosci Res 85:1506–1514. https://doi.org/10.1002/jnr.21275
Noguchi CT, Schechter AN (1985) Sickle hemoglobin polymerization in solution and in cells. Annu Rev Biophys Biophys Chem 14:239–263. https://doi.org/10.1146/annurev.biophys.14.1.239
Nonaka K, Kume N, Urata Y et al (2007) Serum levels of S-glutathionylated proteins as a risk-marker for arteriosclerosis obliterans. Circ J 71:100–105. https://doi.org/10.1253/circj.71.100
Nur E, Brandjes DP, Teerlink T et al (2012) N-acetylcysteine reduces oxidative stress in sickle cell patients. Ann Hematol 91:1097–1105. https://doi.org/10.1007/s00277-011-1404-z
Oder E, Safo MK, Abdulmalik O, Kato GJ (2016) New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo? Br J Haematol 175:24–30. https://doi.org/10.1111/bjh.14264
Ou CN, Rognerud CL (2001) Diagnosis of hemoglobinopathies: electrophoresis versus. HPLC Clin Chim Acta 313:187–194. https://doi.org/10.1016/S0009-8981(01)00672-6
Özpolat T, Chen J, Fu X et al (2014) Effects of N-acetylcysteine in patients with sickle cell disease. Blood 124:4173. https://doi.org/10.1182/blood.V124.21.4173.4173
Padlan EA, Love WE (1985) Refined crystal structure of deoxyhemoglobin S. II. molecular interactions in the crystal. J Biol Chem 260:8280–8291
Pauling L, Itano HA, Singer SJ, Wells IC (1949) Sickle cell anemia, a molecular disease. Science 110(80):543–548. https://doi.org/10.1126/science.110.2865.543
Perutz MF (1970a) Stereochemistry of cooperative effects in haemoglobin. Nature 228:726–734. https://doi.org/10.1038/228726a0
Perutz MF (1970b) The Bohr effect and combination with organic phosphates. Nature 228:734–739. https://doi.org/10.1038/228734a0
Platt O (2008) Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med 358:1362–1369. https://doi.org/10.1056/NEJMct0708272
Platt OS, Brambilla DJ, Rosse WF et al (1994) Mortality in sickle cell disease—life expectancy and risk factors for early death. N Engl J Med 330:1639–1644. https://doi.org/10.1056/NEJM199406093302303
Prange HD, Shoemaker JL, Westen EA et al (2001) Physiological consequences of oxygen-dependent chloride binding to hemoglobin. J Appl Physiol 91:33–38. https://doi.org/10.1152/jappl.2001.91.1.33
Reddy LR, Reddy KS, Surrey S, Adachi K (1997) Role of β87 Thr in the β6 Val acceptor site during deoxy Hb S polymerization. Biochemistry 36:15992–15998. https://doi.org/10.1021/bi9717439
Reiter CD, Wang X, Tanus-Santos JE et al (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8:1383–1389. https://doi.org/10.1038/nm1202-799
Ribeil J-A, Hacein-Bey-Abina S, Payen E et al (2017) Gene therapy in a patient with sickle cell disease. N Engl J Med 376:848–855. https://doi.org/10.1056/NEJMoa1609677
Rolan P, Mercer A, Wootton R, Posner J (1995) Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers. Br J Clin Pharmacol 39:375–380. https://doi.org/10.1111/j.1365-2125.1995.tb04465.x
Safo MK, Kato GJ (2014) Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin. Hematol Oncol Clin North Am 28:217–231. https://doi.org/10.1016/j.hoc.2013.11.001
Singh A, Xu YJ (2016) The cell killing mechanisms of hydroxyurea. Genes (Basel). 7:99
Ueda Y, Nagel RL, Bookchin RM (1979) An increased Bohr effect in sickle cell anemia. Blood 53:472–480
Wales TE, Fadgen KE, Gerhardt GC, Engen JR (2008) High-speed and high-resolution UPLC separation at zero degrees celsius. Anal Chem 80:6815–6820. https://doi.org/10.1021/ac8008862
Waterman MR, Yamaoka K, Dahm L et al (1974) Noncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling. Proc Natl Acad Sci USA 71:2222–2225. https://doi.org/10.1073/pnas.71.6.2222
Weis DD, Engen JR, Kass IJ (2006) Semi-automated data processing of hydrogen exchange mass spectra using HX-Express. J Am Soc Mass Spectrom 17:1700–1703. https://doi.org/10.1016/j.jasms.2006.07.025
Wintrobe MM (2014) Wintrobe’s clinical hematology. In: Wintrobe’s clinical hematology, 13th edn, Part IV, Sect 4, Chap 33
Wishner BC, Ward KB, Lattman EE, Love WE (1975) Crystal structure of sickle-cell deoxyhemoglobin at 5 Å resolution. J Mol Biol 98:179–194. https://doi.org/10.1016/S0022-2836(75)80108-2
Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460–1465. https://doi.org/10.1182/blood-2004-10-3982
Woodard P, Helton KJ, Khan RB et al (2005) Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol. https://doi.org/10.1111/j.1365-2141.2005.05491.x
Yohe ME, Sheffield KM, Mukerji I (2000) Solubility of fluoromethemoglobin S: effect of phosphate and temperature on polymerization. Biophys J 78:3218–3226. https://doi.org/10.1016/S0006-3495(00)76858-5
Zhang Z, Smith DL (1993) Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci 2:522–531
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mandal, A.K., Mitra, A., Das, R. (2020). Sickle Cell Hemoglobin. In: Hoeger, U., Harris, J. (eds) Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. Subcellular Biochemistry, vol 94. Springer, Cham. https://doi.org/10.1007/978-3-030-41769-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-41769-7_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41768-0
Online ISBN: 978-3-030-41769-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)